AstraZeneca COVID Drug Has Monoclonal Antibodies to Prevent Infection for the Immunocompromised, Gets FDA Authorization AstraZeneca's COVID Drug has Monoclonal Antibodies that prevent infection for immunocompromised people, now an emergency authorized by the FDA. by Isaiah Richard